Medical News & Research
24 hours ago
ROS1-positive NSCLC: Taletrectinib FDA-approved with high response rates in TKI-naive disease
FDA
2 days ago
MSI-H/dMMR locally advanced rectal cancer: dostarlimab enables sustained clinical complete responses and organ preservation
FDA
2 days ago
Severe fetal CNS anomalies: add exome sequencing to chromosomal microarray as first-tier testing
International Journal of Gynecology & Obstetrics
2 days ago
ROS1-positive NSCLC: taletrectinib wins FDA approval with high response rates
FDA
Clinical Relevance: High24 hours ago
ROS1-positive NSCLC: Taletrectinib FDA-approved with high response rates in TKI-naive disease
FDA
2 days ago
MSI-H/dMMR locally advanced rectal cancer: dostarlimab enables sustained clinical complete responses and organ preservation
FDA
2 days ago
Severe fetal CNS anomalies: add exome sequencing to chromosomal microarray as first-tier testing
International Journal of Gynecology & Obstetrics